Form 4: Sight Sciences Director Donald Zurbay Receives Stock Grant

Director Donald Zurbay received a grant of 17,366 restricted stock units (RSUs) from Sight Sciences, Inc. on June 6, 2024.

Summary

• Donald Zurbay, a director of Sight Sciences, Inc., received a grant of 17,366 restricted stock units (RSUs) on June 6, 2024.
• The RSUs were granted under the Issuer's Non-Employee Director Compensation Program.
• Each RSU represents a contingent right to receive one share of Sight Sciences' common stock.
• The number of RSUs granted is equal to $120,000 divided by the closing price of the Common Stock on the grant date.
• The RSUs vest on the earlier of June 6, 2025, and the date of the Issuer's 2025 annual meeting of stockholders, contingent upon continued service as a director.
• Following the transaction, Zurbay beneficially owns 117,460 shares, including common stock, RSUs, and shares acquirable through stock options.

Sentiment

Score: 7

Explanation: The document reflects a standard compensation practice, indicating stability and alignment of interests. It's a neutral to slightly positive event.

Positives

• The grant of RSUs aligns the director's interests with the company's performance.
• The vesting schedule incentivizes continued service as a director.

Future Outlook

The RSUs will vest on the earlier of June 6, 2025, and the date of the Issuer's 2025 annual meeting of stockholders, subject to the Reporting Person's continued service as a director on the Company's board of directors through such vesting date.

Industry Context

Director compensation through equity grants is a common practice to align the interests of board members with those of shareholders, incentivizing them to focus on long-term value creation. This is a standard method used across the industry.

Comparison to Industry Standards

• Equity compensation for non-employee directors is a common practice among publicly traded companies, particularly in the technology and healthcare sectors.
• The size of the grant, valued at $120,000, appears to be within the typical range for director compensation at companies of similar size and stage as Sight Sciences.
• Companies like Alcon (ALC) and Johnson & Johnson (JNJ), which operate in related fields, also utilize equity grants as part of their director compensation packages.

Stakeholder Impact

• Shareholders: The grant aligns director interests with shareholder value.
• Employees: The grant reflects the company's commitment to its leadership.

Key Dates